<?xml version="1.0" encoding="UTF-8"?>
<p>To examine the dynamics of TRF1 compacting single human telomeres, we molecularly cloned and purified human TRF1. TRF1, directly interacting with telomeric DNA (
 <xref rid="B13" ref-type="bibr">13</xref>), contains a C-terminal domain (Myb) for binding dsDNA (Double-stranded DNA) and an N-terminal domain (TRFH) for self-dimerization (
 <xref rid="B18" ref-type="bibr">18</xref>,
 <xref rid="B63" ref-type="bibr">63</xref>). The dimerization of TRF1 plays an essential role in shelterin compacting telomeric chromatin (
 <xref rid="B6" ref-type="bibr">6</xref>,
 <xref rid="B9" ref-type="bibr">9</xref>) (Figure 
 <xref ref-type="fig" rid="F2">2A</xref>). We expressed the recombinant protein of TRF1 in 
 <italic>E. coli</italic> cells (Materials and methods). After removing the affinity tag, the purified protein shows homogeneity with &gt;95% purity by SDS-PAGE (Figure 
 <xref ref-type="fig" rid="F2">2B</xref>, inset). Using size exclusion chromatography, we assessed the molecular weight of the purified TRF1, indicating that the protein forms a dimer (Figure 
 <xref ref-type="fig" rid="F2">2B</xref>). To measure the binding affinity (
 <italic>K</italic>
 <sub>d</sub>), we performed the electrophoretic mobility shift assay (EMSA) (Materials and methods, Figure 
 <xref ref-type="fig" rid="F2">2C</xref>). Estimation using the Hill equation (
 <xref rid="B44" ref-type="bibr">44</xref>) gives a 
 <italic>K</italic>
 <sub>d</sub> of 17.5 ± 0.7 nM (mean ± SE, 
 <italic>n</italic> = 3, Figure 
 <xref ref-type="fig" rid="F2">2D</xref>). We use dimer concentrations for TRF1 throughout this work. The 
 <italic>K</italic>
 <sub>d</sub> is lower than the physiological concentration of TRF1, which is estimated to be 21.6 nM (12.2–43.7 nM) using the number of TRF1 in a Hela cell (40 000 molecules/HeLa cell) (
 <xref rid="B64" ref-type="bibr">64</xref>) and the Hela cell volume of 1540 μm
 <sup>3</sup> (760–2730 μm
 <sup>3</sup>) (
 <xref rid="B65" ref-type="bibr">65</xref>).
</p>
